The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, April 10, 2024
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with ...
read more
Wednesday, April 10, 2024
BrainStorm Cell Therapeutics Inc. , a developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it received written ...
read more
Wednesday, April 10, 2024
Essential Pharma, a specialty pharma group has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd. Renaissance ...
read more
Wednesday, April 10, 2024
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics. The transaction brings an operational good ...
read more
Wednesday, April 10, 2024
Lisata Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (“ODD”) to LSTA1, the Company’s ...
read more
Wednesday, April 10, 2024
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk under a framework agreement that initially is contemplated to ...
read more
UroGen Pharma Ltd. announced that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., ...
read more
Biognosys, a provider of mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company powering precision proteomics to enable the ...
read more
Diagonal Therapeutics has launched with $128 million in financing. The Series A was co-led by BVF Partners and Atlas Venture, with participation from ...
read more
Lipella Pharmaceuticals Inc. announced that the FDA granted a Type C meeting request to discuss the company’s proposed Phase-2b clinical trial design ...
read more
Addex Therapeutics announced the launch of Neurosterix, a company focused on developing allosteric modulators for the treatment of underserved ...
read more
SpineThera, Inc., a clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone ...
read more
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. and mAbxience, a Fresenius Kabi majority-owned group with...
read more
Ligand Pharmaceuticals announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of seasoned industry ...
read more
Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), announced a multi-year strategic partnership with Merck KGaA, ...
read more